#SVML Sovereign Metals – Sovereign Initiates Major PFS Drill Program
SOVEREIGN INITIATES MAJOR PFS DRILL PROGRAM AT KASIYA · 12,000m drilling program commenced at Kasiya to upgrade higher-grade Mineral Resource areas to underpin conversion to Reserves as part of the planned PFS · Deeper drilling to target extensions to Indicated zones at depth to base of saprolite (~25m) · Expansion of the overall mineralised footprint through extensional and […]
#POW Power Metal Resources – First Development Resources – Pre-IPO Financing
Power Metal Resources PLC (LON:POW) the London listed exploration company seeking large-scale metal discoveries across its global project portfolio, announces its subsidiary First Development Resources Limited (“First Development” or “FDR”) has undertaken a 1,125,000 Pre-IPO financing (“Financing”). FDR is planning to list on the London capital markets in Q3 2022 (the “IPO”) and is focussed on district-scale exploration opportunities in Australia . HIGHLIGHTS · First Development […]
#BRES Blencowe Resources – Airborne EM Program Commences at Akelikongo Nickel Project
Highlights · Blencowe commences exploration program at synergistic nickel sulphide project · Substantial 3,200-line kilometres of survey to be conducted · Partnering with highly regarded Airborne survey firm in SkyTEM Aps · Targeting increased definition of several targets identified in project data review Blencowe Resources Plc (“Blencowe Resources” or the “Company”) (LSE: BRES) is pleased to announce the commencement […]
Quoted Micro 30 May 2022
AQUIS STOCK EXCHANGE Silverwood Brands (SLWD) has secured a deal to buy Balmonds Skincare, which manufactures products for people with skin conditions, such as eczema, psoriasis and dermatitis. The total cost of the acquisition will be up to £8m, all in shares, depending on achievement of performance criteria. A shareholder loan will also be acquired […]
#MNRG MetalNRG – Annual Report and Notice of AGM
MetalNRG plc (LON:MNRG), the natural resources and energy investment company, announces that, further to the announcement of final results for the year ended 31 December 2021, published on 29 April 2022, (“Final Results”), the Company’s Annual Report and Financial Statements has been published and is available on the Company’s website: www.metalnrg.com. The Financial Statements for the year ended 31 December 2021 contained […]
Rick Rule’s Top Picks: May 25, 2022 – #SVML Sovereign Metals, #EQX Equinox Gold and #CTM Centaurus Metals
MARKET OUTLOOK: This bearish macro picture masks an ongoing bull market in both precious metals, and industrial materials. The precious metals bull market will continue, given quantitative easing, government debt and deficits, and particularly negative real interest rates. Industrial materials markets will be led by population growth, an increase in frontier markets living standards, negative […]
#MNRG MetalNRG – Legal Proceedings Update
MetalNRG plc (“MetalNRG” or the “Company”) announces that, in its continuing civil legal proceedings in the English High Court against Brit Energy Holdings LLP (the “LLP”), Mr Pierpaolo Rocco (“Mr Rocco”) and BritNRG Limited (the “Joint Venture Company”), it has filed and served an application for summary judgment against the LLP and the Joint Venture Company […]
#SVML Sovereign Metals – ESG Framework Advances Initiatives in Malawi
SOVEREIGN ESG FRAMEWORK ADVANCES SOCIAL INITIATIVES IN MALAWI · Environmental, Social and Governance (ESG) framework established to advance Sovereign’s Corporate Social Responsibility in Malawi · Sovereign continues to undertake several initiatives to assist in the development of Malawi and its local communities – Promoting education in Malawi through a Schools Upgrade Program and […]
#POLB Poolbeg Pharma – US patents granted for POLB 001 and POLB 002
26 May 2022 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has been granted patents by the US Patent and Trademark Office (USPTO) for POLB 001, a small molecule immunomodulator for the treatment of severe influenza and POLB 002, a first-in-class, intranasally administered […]
#ORPH Open Orphan – Completion of Nominated Adviser due diligence
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that further to the appointment of Liberum Capital Limited (“Liberum”) as its Nominated Adviser and Joint Broker on 28 April 2022, Liberum has confirmed that is has completed […]